Market Tracker

04/29 5:16pm ET

Vanda Pharmaceuticals Inc (NASDAQ:VNDA)

8.90
Delayed Data
As of Apr 29
 -0.265 / -2.89%
Today’s Change
6.91
Today|||52-Week Range
14.50
-4.40%
Year-to-Date

Today’s Trading

Previous close9.16
Today’s open9.16
Day’s range8.89 - 9.35
Volume521,758
Average volume (3 months)573,864
Market cap$395.0M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-270.91%
Earnings growth (this year)-33.33%
Earnings growth (next 5 years)+19.10%
Revenue growth (last year)+119.16%
P/E ratioNM
Price/Sales3.58
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
SGNTSagent Pharmaceutica...-0.38-3.16%
ACRSAclaris Therapeutics...-1.28-6.48%
PGNXProgenics Pharmaceut...-0.19-3.45%
OMEDOncoMed Pharmaceutic...-1.17-8.62%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$109.9M
Annual profit (last year)-$39.9M
Net profit margin-36.27%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mihael Hristos Polymeropoulos
Chief Financial Officer, Treasurer &
Senior VP
James Patrick Kelly
Corporate headquarters
Washington, District Of Columbia

Forecasts